AstraZeneca’s COVID-19 Antibody Treatment Shows Promising Results in Immunocompromised Individuals

AstraZeneca, COVID-19, antibody treatment, immunocompromised individuals, enhanced protection, clinical trials, monoclonal antibodies, virus neutralization, immune response.